MedTrace Logo

Prevalence and Reversibility of Lung Hyperinflation in Asthma

NCT01573364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2012-04-09

No results posted yet for this study

Summary

The aim of this observational study is to evaluate the pulmonary hyperinflation and its immediate reversibility to a short acting beta2 agonist test in uncontrolled persistent asthmatic patients with dyspnea.

Conditions

Sponsors & Collaborators

  • Chiesi Farmaceutici S.p.A.

    lead INDUSTRY

Principal Investigators

  • Capucine de Meynard, MD · Chiesi S.A.

  • Daniel Dusser, MD, Prof · Hopital Cochin Paris France

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-10-31
Completion
2012-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01573364 on ClinicalTrials.gov